Propofol attenuates oxidative stress-induced PC12 cell injury via p38 MAP kinase dependent pathway

Authors: WU, Xing-jun1; ZHENG, Yong-jun2; CUI, Yong-yao1; ZHU, Liang1; LU, Yang; CHEN, Hong-zhuan

Source: Acta Pharmacologica Sinica, Volume 28, Number 8, August 2007 , pp. 1123-1128(6)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Aim: To investigate the neuroprotective effect of propofol and its intracellular mechanism on neurons in vitro.Methods: Cell viability was determined with 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide reduction. Apoptotic cell death was determined by Hoechst 33258 staining and a fluorescence-activated cell sorter. The caspase-3 activity was measured by fluorometric assay. Mitogen-activated protein (MAP) kinase phosphorylation was detected with Western blotting. Results: The pretreatment of rat pheochromocytoma cell line PC12 with propofol (1-10 μmol/L) resulted in a significant recovery from hydrogen peroxide (H2O2)-induced cell death and the inhibition of H2O2 induced caspase-3 activation and PC12 cell apoptosis. Propofol inhibited the H2O2-induced p38 MAP kinase, but not c-Jun N-terminal kinase or extracellular signal-regulated kinase 1 and 2 activations. Conclusion: Propofol might attenuate H2O2-induced PC 12 cell death through the inhibition of signaling pathways mediated by the p38 MAP kinase.

Keywords: propofol; oxidative stress; PC12 cells; apoptosis; p38 MAP kinase

Document Type: Research article

DOI: 10.1111/j.1745-7254.2007.00610.x

Affiliations: 1: Department of Pharmacy, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 2: Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.39 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A